Literature DB >> 20409746

Advances in radiotherapy for head and neck cancer.

S A Bhide1, C M Nutting.   

Abstract

Radiotherapy and surgery are the principal curative modalities in treatment of head and neck cancer. Conventional (two dimensional, 2D and three-dimensional conformal radiotherapy, 3DCRT) result in significant side-effects and altered quality of life. Intensity modulated radiotherapy (IMRT) can spare the normal tissues, while delivering a curative dose to the tumour bearing tissues. Technical advances like volumetric intensity modulated arc therapy (VMAT) have helped optimise IMRT further. Image guided radiotherapy (IGRT) can be used to aid target delineation and also help reduce the PTV margins to further enhance the therapeutic ratio. Particle therapy using protons provides significant advantage in terms of normal tissue sparing and is recommended for small cranial tumours and in radiotherapy for paediatric patients. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20409746     DOI: 10.1016/j.oraloncology.2010.03.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.

Authors:  Silke Tribius; Marieclaire Raguse; Christian Voigt; Adrian Münscher; Alexander Gröbe; Cordula Petersen; Andreas Krüll; Corinna Bergelt; Susanne Singer
Journal:  Strahlenther Onkol       Date:  2015-03-08       Impact factor: 3.621

Review 2.  Radioprotection: smart games with death.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

3.  Radiotherapy-induced xerostomia, pre-clinical promise of LMS-611.

Authors:  Claire Paterson; B Caldwell; S Porteous; A McLean; C M Messow; M Thomson
Journal:  Support Care Cancer       Date:  2015-07-05       Impact factor: 3.603

4.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

5.  Analysis of factors influencing the development of xerostomia during intensity-modulated radiotherapy.

Authors:  Ken Randall; Jason Stevens; Juan Fernando Yepes; Marcus E Randall; Mahesh Kudrimoti; Jonathan Feddock; Jing Xi; Richard J Kryscio; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-03-22

6.  Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT.

Authors:  Magdalena Peszynska-Piorun; Julian Malicki; Wojciech Golusinski
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

7.  Effect of fractionated radiotherapy on the parotid gland: an experimental study in Brazilian minipigs.

Authors:  Roberta Targa Stramandinoli-Zanicotti; Laurindo Moacir Sassi; Juliana Lucena Schussel; Maria Fernanda Torres; Melissa Funchal; Gustavo Henrique Smaniotto; José Luis Dissenha; Andre Lopes Carvalho
Journal:  Int Arch Otorhinolaryngol       Date:  2013-04

8.  Dosimetric comparison for volumetric modulated arc therapy and intensity-modulated radiotherapy on the left-sided chest wall and internal mammary nodes irradiation in treating post-mastectomy breast cancer.

Authors:  Qian Zhang; Xiao Li Yu; Wei Gang Hu; Jia Yi Chen; Jia Zhou Wang; Jin Song Ye; Xiao Mao Guo
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

9.  A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.

Authors:  Wen-Ze Qiu; Xing-Si Peng; Hai-Qun Xia; Pei-Yu Huang; Xiang Guo; Ka-Jia Cao
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-25       Impact factor: 4.553

10.  Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapy.

Authors:  Whoon Jong Kil; Christina Kulasekere; Ronald Derrwaldt; Jacob Bugno; Craig Hatch
Journal:  Oncotarget       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.